Malignant cell interactions with cells of the hepatic sinusoids mediate primarily the development of colorectal cancer liver metastasis

Annals of Gastroenterology

Volumn 21, Issue 2, 2008, Pages 98-108

  Paschos, Kostas ^a,b   Canovas, D ^a   Bird, N ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NONE   (Greece)

Author keywords

Colorectal cancer; Hepatic sinusoids; Kupffer cells; Liver metastasis; Pit cells; Sinusoidal endothelial cells; Stellate cells

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; FAS LIGAND; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NERVE CELL ADHESION MOLECULE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN D2; PROSTAGLANDIN E2; SCATTER FACTOR; THROMBOXANE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

CANCER CELL; CANCER INVASION; CANCER MORTALITY; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL SURVIVAL; CELL TRANSFORMATION; COLORECTAL CANCER; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; KUPFFER CELL; LIVER BLOOD VESSEL; LIVER METASTASIS; LIVER SINUSOID; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SECRETION; REVIEW; STELLATE CELL; SYSTEMIC CIRCULATION; TUMOR VASCULARIZATION;

EID: 62349100201     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Kleivi k, Lind GE, Diep CB, et al. Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer. 2007;6:2.
2. Miranda E, Destro A, Malesci A, et al. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer. 2006;95:1101-1107.
3. Diep CB, Kleivi k, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer. 2006; 45:31-41.
4. Diep CB, Teixeira MR, Thorstensen L, et al. Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients. Mol Cancer. 2004;3:6.
5. Nakao K, Shibusawa M, Ishihara A, et al. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer. 2001;91:721-726.
6. Aragane H, Sakakura C, Nakanishi M, et al. Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization. International journal of cancer. 2001;94:623-629.
7. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-458.
8. Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther. 2005;4:365-370.
9. Guarino M, Rubino B, Ballabio G. The role of epithelialmesenchymal transition in cancer pathology. Pathology. 2007;39:305-318.
10. Minard ME, Ellis LM, Gallick GE. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis. 2006;23:301-313.
11. Bates RC. Colorectal cancer progression: integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT). Cell Cycle. 2005;4:1350-1352.
12. Vincan E, Brabletz T, Faux MC, Ramsay RG. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. Cells Tissues Organs. 2007;185:20-28.
13. Weinberg R. The biology of cancer: Garland Science (Taylor & Francis Group); 2007.
14. Athanassiadou P, Grapsa D. Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature. Cancer Metastasis Rev. 2006;25:507-519.
15. Pelkey TJ, Frierson HF, Jr., Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem. 1996;42:1369-1381.
16. Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 1984;44:3584-3592.
17. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol. 2007;16:3-5.
18. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, Matsuura T. The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol. 2007;13:821-5.
19. Timmers M, Vekemans k, Vermijlen D, et al. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. International journal of cancer. 2004;112:793-802.
20. Vekemans k, Braet F. Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol. 2005;11:5095-102.
21. Vekemans K, Braet F, Wisse E. DiO-labeled CC531s colon carcinoma cells traverse the hepatic sinusoidal endothelium via the Fas/FasL pathway. J Gastrointest Surg. 2004;8:371-2; author reply 2.
22. Patanaphan V, Salazar OM, Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J. 1988;81:1109-1112.
23. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038-1045.
24. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865-875.
25. Mignon F, Mesurolle B. [Local recurrence and metastatic dissemination of renal cell carcinoma: clinical and imaging characteristics]. J Radiol. 2003;84:275-284.
26. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: A review. J Surg Oncol. 2006;94(1):68-80.
27. Elvevold K, Smedsrod B, Martinez I. The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. American journal of physiology. 2008;294:G391-400.
28. Braet F, Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol. 2002;1:1.
29. Enomoto k, Nishikawa Y, Omori Y, et al. Cell biology and pathology of liver sinusoidal endothelial cells. Med Electron Microsc. 2004;37:208-215.
30. Shiratori Y, Tananka M, Kawase T, Shiina S, Komatsu Y, Omata M. Quantification of sinusoidal cell function in vivo. Seminars in liver disease. 1993;13:39-49.
31. Breiner kM, Schaller H, Knolle PA. Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver targeting of hepatotropic microorganisms. Hepatology. 2001;34(4 Pt 1):803-808.
32. Knolle PA, Schmitt E, Jin S, et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology. 1999;116:1428-1440.
33. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology. 1998;27:1652-1660.
34. Edmiston KH, Shoji Y, Mizoi T, Ford R, Nachman A, Jessup JM. Role of nitric oxide and superoxide anion in elimination of low metastatic human colorectal carcinomas by unstimulated hepatic sinusoidal endothelial cells. Cancer Res. 1998;58:1524-1531.
35. Rocha M, kruger A, Van Rooijen N, Schirrmacher V, Umansky V. Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. International journal of cancer. 1995;63:405-411.
36. Wang HH, McIntosh AR, Hasinoff BB, et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 2000;60:5862-5869.
37. Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem. 2001;276:33762-772.
38. Nakatani K, Kaneda k, Seki S, Nakajima Y. Pit cells as liver-associated natural killer cells: morphology and function. Med Electron Microsc. 2004;37:29-36.
39. Luo DZ, Vermijlen D, Ahishali B, et al. On the cell biology of pit cells, the liver-specific NK cells. World J Gastroenterol. 2000;6:1-11.
40. Vanderkerken K, Bouwens L, Wisse E. Characterization of a phenotypically and functionally distinct subset of large granular lymphocytes (pit cells) in rat liver sinusoids. Hepatology. 1990;12:70-75.
41. Vanderkerken K, Bouwens L, De Neve W, et al. Origin and differentiation of hepatic natural killer cells (pit cells). Hepatology. 1993;18:919-925.
42. Vanderkerken K, Bouwens L, Van Rooijen N, Van den Berg K, Baekeland M, Wisse E. The role of Kupffer cells in the differentiation process of hepatic natural killer cells. Hepatology. 1995;22:283-290.
43. Timonen T, Helander TS. Natural killer cell-target cell interactions. Current opinion in cell biology. 1997;9:667-73.
44. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annual review of immunology. 1994;12:735-773.
45. Luo D, Vanderkerken K, Bouwens L, et al. The role of adhesion molecules in the recruitment of hepatic natural killer cells (pit cells) in rat liver. Hepatology. 1996;24:1475-1480.
46. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood reviews. 2006;20:123-137.
47. Vermijlen D, Luo D, Robaye B, Seynaeve C, Baekeland M, Wisse E. Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology. 1999;29:51-56.
48. Winau F, Hegasy G, Weiskirchen R, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 2007;26:117-129.
49. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125-172.
50. Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct. 2003;28:105-112.
51. Melton AC, Yee HF. Hepaticstellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis. Hepatology. 2007;45:1446-1453.
52. Ankoma-Sey V, Matli M, Chang KB, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene. 1998;17:115-121.
53. Yamada M, Blaner WS, Soprano DR, Dixon JL, Kjeldbye HM, Goodman DS. Biochemical characteristics of isolated rat liver stellate cells. Hepatology. 1987;7:1224-1229.
54. Asahina K, Sato H, Yamasaki C, et al. Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver. Am J Pathol. 2002;160:2191-2205.
55. Yoshino R, Miura K, Segawa D, et al. Epimorphin expression and stellate cell status in mouse liver injury. Hepatol Res. 2006;34:238-249.
56. Mullhaupt B, Feren A, Fodor E, Jones A. Liver expression of epidermal growth factor RNA. Rapid increases in immediate- early phase of liver regeneration. J Biol Chem. 1994;269:19667-19670.
57. Maher JJ. Interactions between hepatic stellate cells and the immune system. Seminars in liver disease. 2001;21:417-426.
58. Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol. 2008;20:68-74.
59. Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. American journal of physiology. 2005;289:G571-G578.
60. March S, Graupera M, Rosa Sarrias M, et al. Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol. 2007;170:176-187.
61. Aleffi S, Petrai I, Bertolani C, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 2005;42:1339-1348.
62. Qamar A, Sheikh SZ, Masud A, et al. In vitro and in vivo protection of stellate cells from apoptosis by leptin. Dig Dis Sci. 2006;51:1697-1705.
63. Di Sario A, Baroni GS, Bendia E, et al. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. Am J Physiol. 1997;273(1 Pt 1):G39-48.
64. Faouzi S, Lepreux S, Bedin C, et al. Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest. 1999;79:485-493.
65. Olaso E, Salado C, Egilegor E, et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 2003;37:674-485.
66. Shimizu S, Yamada N, Sawada T, et al. In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. Jpn J Cancer Res. 2000;91:1285-1295.
67. Wirz W, Antoine M, Tag CG, et al. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation. 2008.
68. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006;26:1175-1186.
69. Naito M, Hasegawa G, Ebe Y, Yamamoto T. Differentiation and function of Kupffer cells. Med Electron Microsc. 2004;37:16-28.
70. Roberts RA, Ganey PE, Ju C, kamendulis LM, Rusyn I, Klaunig JE. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci. 2007;96:2-15.
71. Ho JS, Buchweitz JP, Roth RA, Ganey PE. Identification of factors from rat neutrophils responsible for cytotoxicity to isolated hepatocytes. J Leukoc Biol. 1996;59:716-724.
72. Smedsrod B, De Bleser PJ, Braet F, et al. Cell biology of liver endothelial and Kupffer cells. Gut. 1994;35:1509-1516.
73. Fukuda M, Yokoyama H, Mizukami T, et al. Kupffer cell depletion attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide treatment. J Gastroenterol Hepatol. 2004;19:1155-1562.
74. Rolfe M, James NH, Roberts RA. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis. 1997;18:2277-2280.
75. Holden PR, Hasmall SC, James NH, et al. Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin. Cell Mol Biol. 2000;46:29-39.
76. Rusyn I, Tsukamoto H, Thurman RG. WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis. 1998;19:1217-1222.
77. Rusyn I, Kadiiska MB, Dikalova A, et al. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol Pharmacol. 2001;59:744-750.
78. Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res. 1987;47(24 Pt 1):6686-6691.
79. Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology. 1996;23:1224-1231.
80. Gardner CR, Wasserman AJ, Laskin DL. Liver macrophage-mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets. Hepatology. 1991;14:318-324.
81. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
82. Decker T, Lohmann-Matthes ML, karck U, Peters T, Decker K. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukoc Biol. 1989;45:139-146.
83. Aarons CB, Bajenova O, Andrews C, et al. Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells. Clin Exp Metastasis. 2007;24:201-209.
84. Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis. 1999;17:481-488.
85. Minami S, Furui J, Kanematsu T. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res. 2001;61:2732-2735.
86. Roh MS, Wang L, Oyedeji C, et al. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery. 1990;108:400-4; discussion 4-5.
87. Phillips NC. Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity. Cancer Metastasis Rev. 1989;8:231-252.